Skip to main content
FinSpry Logo
FinSpry
STRO logo
STRO
(NASDAQ)
Sutro Biopharma, Inc.
$30.03-- (--)
Loading... - Market loading
OverviewFinancialsForecastStatisticsDividendsHistoricalProfile

Sutro Biopharma (STRO) Stock Price & Financial Analysis

Sutro Biopharma Stock Price Chart

Price Chart

Loading chart...

Financial Metrics & Key Statistics

Fundamental metrics, valuation ratios, and profitability indicators

Day's Range$29.29 - $31.79
52-Week High$43.85
52-Week Low$6.74
Open$29.29
Volume377.22K
Average Volume (3M)307.68K
Market Cap3.88M
Shares Outstanding130.82K
Price to Sales (P/S)0.04
Price to Book (P/B)-0.06
EV/EBITDA0.53
Revenue (TTM)99.61M
Net Income (TTM)-153.60M
Free Cash Flow (TTM)-152.14M
EPS (TTM)$-23.94
Profit Margin-154.21%
Operating Margin-105.93%
50-Day MA$31.81
200-Day MA$18.04
52-Week Change273.27%
Annual Dividend$0.00
Dividend Yield0.00%

Frequently Asked Questions About Sutro Biopharma

What is the current stock price for STRO?

As of the latest trading session, STRO stock trades at $30.03. The 52-week range is $6.74–$43.85, with a day range of $29.29–$31.79.

What is the P/E ratio for STRO?

The P/E ratio (Price-to-Earnings) for STRO is shown in the Key Statistics section. This valuation metric helps compare Sutro Biopharma, Inc. to industry peers.

Does STRO pay dividends?

Sutro Biopharma does not currently pay a regular dividend. The company reinvests earnings into growth and operations. Check the Dividends tab for historical dividend information.

What do analysts recommend for STRO?

Based on 13 analysts, the consensus for STRO is Buy. The average 12-month price target is $NaN, representing a NaN% downside from the current price.

What is the market cap of STRO?

Sutro Biopharma's market capitalization is $3.9M, classifying it as a micro-cap company. Sutro Biopharma operates in the Healthcare sector within the Biotechnology industry.